MediWoundvsNewmont

MDWD and NEM stock compared: price, dividend, valuation and results, from SEC filings.

MediWound (MDWD) has a market value of $174M and Newmont (NEM) $103B. Over the last year, with dividends, MDWD moved -23.9% and NEM +9.2%. Dividend yield: MDWD none, NEM 1.09%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MDWD$174M

    NEM$103B

    NEM is 590 times MDWD

  • Revenue, 12 months

    MDWD$17M

    NEM$26.6B

    NEM is 1,569 times MDWD

  • Net income, 12 months

    MDWD-$24M

    NEM$9.2B

  • Operating margin

    MDWD-149.0%

    NEM–

  • ROIC

    MDWD-45.8%

    NEM22.0%

    67.7 points apart

  • P/E

    MDWD–

    NEM11.2

  • Dividend yield

    MDWD0.0%

    NEM1.1%

    1.1 points apart

  • 5-year return

    MDWD-32.4%

    NEM+91.9%

    124.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MDWD-32.4%

NEM+91.9%

10020020222023202420252026
Returns by period
PeriodMDWDWith dividendsNEMWith dividends
1 year since November 19, 2025-23.9%Price -23.9%+9.2%Price +8.2%
3 years since November 20, 2023+58.8%+16.7% a yearPrice +58.8%+174.3%+40.0% a yearPrice +159.0%
5 years since November 19, 2021-32.4%-7.5% a yearPrice -32.4%+91.9%+13.9% a yearPrice +67.4%
10 years since November 22, 2016-63.4%-9.6% a yearPrice -63.4%+264.8%+13.8% a yearPrice +185.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MDWDMediWoundNEMNewmont

Valuation

MDWDNEM
Valuation
Price$13.59$94.68
Market value$174M$103B
Enterprise value (EV)–$99.3B
P/E–11.2
P/E, 5-year median–15.6
P/B4.02.9
EV/EBIT–7.1
Free cash flow yield–9.8%

Results and growth

MDWDNEM
Results and growth
Revenue, 12 months$17M$26.6B
Net income, 12 months-$24M$9.2B
Free cash flow, 12 months-$22M$10.1B
Earnings per share, 12 months-$2.10$8.60
Revenue growth, year on year-16.1%21.3%
Revenue growth a year, past-4.9%over 5 years+14.5%over 5 years
EPS growth a year, past–+12.7%over 5 years

Margins and returns on capital

MDWDNEM
Margins and returns on capital
Gross margin19.2%69.2%
Operating margin-149.0%–
Net margin-140.8%34.7%
ROIC-45.8%22.0%
ROE-54.7%26.7%

Balance sheet

MDWDNEM
Balance sheet
Cash$4.8M$8.8B
Total debt–$5.1B
Net debt / EBITDA–-0.2
Interest cover-10.3×–

Dividends and buybacks

MDWDNEM
Dividends and buybacks
Dividend yield–1.1%
Dividend per share, 12 months–$1.03
Dividend growth a year, past––
Buyback yield–2.2%
Shareholder yield–3.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MDWD or NEM

Didn't find what you were looking for?

Ask us
Which is bigger, MediWound or Newmont?

By market value, Newmont ($103B) is about 590.5 times MediWound ($174M), at today's prices.

How did MDWD and NEM stock do over the last 10 years?

Since November 22, 2016, MDWD's price moved -63.4% and NEM's +185.2%. With dividends: MDWD -63.4% (-9.6% a year), NEM +264.8% (+13.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MDWD or NEM?

The dividend yield at today's price is none for MediWound and 1.09% for Newmont. Over the last twelve months they paid – and $1.03 per share.

Which has the higher profit margins, MediWound or Newmont?

Over the last twelve months, the net margin was -140.8% for MediWound and 34.7% for Newmont, and the operating margin -149.0% and –. Revenue was $17M and $26.6B.

Which is the better investment, MediWound or Newmont?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.